Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Epidemiologic Reviews
|
July 18, 2002
Analysis of randomized controlled trials
Peter Peduzzi, William Henderson, Pamela Hartigan, et al.
Plos One
|
January 27, 2017
Supporting Better Evidence Generation and Use within Social Innovation in Health in Low- and Middle-Income Countries: A Qualitative Study
Madeleine Ballard, Jenny Tran, Fred Hersch, et al.
Heart & Lung : the Journal of Critical Care
|
September 12, 2006
The synergistic effect of heart disease and diabetes on self-management, symptoms, and health status
Christi Deaton, Laura P Kimble, Emir Veledar, et al.
JAMA
|
September 13, 2007
Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial
Rex L Jamison, Pamela Hartigan, James S Kaufman, et al.
JAMA Internal Medicine
|
December 4, 2013
Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials
Kathleen Stergiopoulos, William E Boden, Pamela Hartigan, et al.
Clinical Trials (London, England)
|
November 11, 2005
Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study
Rex L Jamison, Pamela Hartigan, J Michael Gaziano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 25, 2009
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
Christopher B Brady, J Michael Gaziano, Roberta A Cxypoliski, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 13, 2018
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Zugui Zhang, Philip Jones, William S Weintraub, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trials
Michael E Farkouh, William E Boden, Vera Bittner, et al.
Journal of the American College of Cardiology
|
February 2, 2019
Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes
Michael E Farkouh, Mandeep S Sidhu, Maria M Brooks, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Epidemiologic Reviews
|
July 18, 2002
Analysis of randomized controlled trials
Peter Peduzzi, William Henderson, Pamela Hartigan, et al.
Plos One
|
January 27, 2017
Supporting Better Evidence Generation and Use within Social Innovation in Health in Low- and Middle-Income Countries: A Qualitative Study
Madeleine Ballard, Jenny Tran, Fred Hersch, et al.
Heart & Lung : the Journal of Critical Care
|
September 12, 2006
The synergistic effect of heart disease and diabetes on self-management, symptoms, and health status
Christi Deaton, Laura P Kimble, Emir Veledar, et al.
JAMA
|
September 13, 2007
Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial
Rex L Jamison, Pamela Hartigan, James S Kaufman, et al.
JAMA Internal Medicine
|
December 4, 2013
Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials
Kathleen Stergiopoulos, William E Boden, Pamela Hartigan, et al.
Clinical Trials (London, England)
|
November 11, 2005
Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study
Rex L Jamison, Pamela Hartigan, J Michael Gaziano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 25, 2009
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
Christopher B Brady, J Michael Gaziano, Roberta A Cxypoliski, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 13, 2018
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Zugui Zhang, Philip Jones, William S Weintraub, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trials
Michael E Farkouh, William E Boden, Vera Bittner, et al.
Journal of the American College of Cardiology
|
February 2, 2019
Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes
Michael E Farkouh, Mandeep S Sidhu, Maria M Brooks, et al.
Page
of 2